Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
10
×
startups
10
×
life sciences
biotech
national top stories
boston blog main
fda
boston top stories
clinical trials
deals
new york blog main
san francisco blog main
boston
investing
medical device
new york top stories
san diego blog main
san diego top stories
san francisco top stories
sanofi
cancer
chronic rhinosinusitis
decibel therapeutics
drugs
flagship pioneering
glaxosmithkline
ipo
laurence reid
lyra therapeutics
parkinson's disease
pulmonary arterial hypertension
raleigh-durham blog main
renaissance capital
san diego
san francisco
sr one
steven holtzman
texas blog main
texas top stories
vc
What
therapeutics
10
×
drug
medicines
new
biotech
disease
ago
based
company
debut
developing
drugs
field
latest
million
momentum
raised
tech
treat
year
years
adding
address
adds
aiming
aims
allosteric
announced
approach
athena
backs
bacteria
balance
bets
big
bio
biopharma
black
build
building
Language
unset
Current search:
therapeutics
×
startups
×
" national blog main "
×
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Delivery Robots in Big D, Rodriguez Leaves the Station, & More TX Tech
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed